Treatment with stromal vascular fraction of Peyronie's disease - a study protocol.

Peyronie´s disease is the result of an acquired fibrotic plaque in the tunica albuginea. It remains unknown why the condition appears, but it seems to affect up to 9% of all men. It can result in a debilitating curvature of the erect penis, which has extensive impact on the quality of life for many men. Thus, the disease may result in low self-esteem, depression and impaired sexual performance.

This is a prospective pilot study investigating the feasibility and safety of stromal vascular fraction injection into the plaque of 22 men with Peyronie´s disease in the chronic phase. The stromal vascular fraction is obtained from a small liposuction of 250 ml fat in general anaesthesia and injected the same day.

We hope to show that injection of stromal vascular fraction is safe and effective in reducing curvature in men with Peyronie´s disease.

The study was made possible with funding from: the Region of Southern Denmark, Louis-Hansen Fund, Lizzi and Mogens Staal Fund, Karola Jørgensen Fund, Marie and Børge Kroghs Fund, the Senior Doctors Research Fund OUH, the Fund for gentle Surgery OUH and the PhD fund of the executive board of the South West Denmark Hospital. The funding sources had no influence on the trial design, data collection, analysis or publication.

gov NCT04771442, EudraCT 2020-004297-22, Danish Medicines Agency 2020090057, National Ethics Committee 74705 and Danish Data Protection Agency (record no. 1/21757).

Danish medical journal. 2023 Sep 22*** epublish ***

Majken Højrup Wiborg, Rasmus Krøijer, Birgitte Schantz Laursen, Lars Lund

Department of Urology, Hospital South West Jutland, Region of Southern Denmark., Faculty of Health Sciences, University of Southern Denmark., Sexology Centre, Aalborg University Hospital.